AGP Picks
View all

American Tech Today
Provided by AGP

American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 28, 2026

GoldInxs Mining Corp. Announces $1,150,000 Private Placement Offering
Sep. 28, 2026

GoldInxs Mining Corp. Announces $1,150,000 Private Placement Offering

Indeterminate GlobeNewswire
Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026
Sep. 28, 2026

Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026

Indeterminate GlobeNewswire
NVIDIA Announces a $150 Billion Share Repurchase Authorization Increase
Sep. 28, 2026

NVIDIA Announces a $150 Billion Share Repurchase Authorization Increase

Indeterminate GlobeNewswire
Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition
Sep. 28, 2026

Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition

Indeterminate GlobeNewswire
MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
Sep. 28, 2026

MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

Indeterminate GlobeNewswire
Hudbay Enhances Gold Production Profile at Snow Lake, Extends Reserve Mine Life to 18 Years and Identifies Further Growth Potential from Resource Conversion and the Britannia Gold Project
Sep. 28, 2026

Hudbay Enhances Gold Production Profile at Snow Lake, Extends Reserve Mine Life to 18 Years and Identifies Further Growth Potential from Resource Conversion and the Britannia Gold Project

Indeterminate GlobeNewswire
Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA
Sep. 28, 2026

Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA

Indeterminate GlobeNewswire
NVIDIA Launches Open Agent Safety Platform to Secure Agents From Testing to Deployment
Sep. 28, 2026

NVIDIA Launches Open Agent Safety Platform to Secure Agents From Testing to Deployment

Indeterminate GlobeNewswire
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition
Sep. 28, 2026

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition

Indeterminate GlobeNewswire
Other World Computing (OWC) to Showcase Unparalleled Roster of Memory Cards and Readers, Storage, and Connectivity Innovations at CABSAT 2026
Sep. 28, 2026

Other World Computing (OWC) to Showcase Unparalleled Roster of Memory Cards and Readers, Storage, and Connectivity Innovations at CABSAT 2026

Indeterminate GlobeNewswire
VSMC Celebrates the Grand Opening of Its First 300mm Fab in Singapore
Sep. 28, 2026

VSMC Celebrates the Grand Opening of Its First 300mm Fab in Singapore

Indeterminate GlobeNewswire
Crypto News Today: AlphaPepe Presale Stage 20 Sold Out While Ethereum Price Prediction Targets $12,000
Sep. 28, 2026

Crypto News Today: AlphaPepe Presale Stage 20 Sold Out While Ethereum Price Prediction Targets $12,000

Indeterminate GlobeNewswire
HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid Tumors
Sep. 28, 2026

HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid Tumors

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

American Tech Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.